Form 4 for ARQT Arcutis Biotherapeutics, Inc.

Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-12 · accession 0002065881-25-000027 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-06-16	2025-06-12	ARQT	Heron Patrick J	Dir, 10%	A - Grant	$0.00	+7,609	26.4K	+40%	$0
D	2025-06-16	2025-06-12	ARQT	Heron Patrick J	Dir, 10%	A - Grant	$0.00	+20.6K	20.6K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-06-12	A	A	7,609	$0.00	26,435	D	—	—	(F1) Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 23, 2024, maintained by the Company.
2	Derivative	Stock Option (right to buy)	2025-06-12	A	A	20,568	$0.00	20,568	D	$13.50 · — to 2035-06-12	20,568 Common Stock	(F6) The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.